atorvastatin has been researched along with Carcinoma, Squamous Cell in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Dong, CD; Ge, Y; Li, X; Li, Z; Liu, K; Lu, Q; Peng, F; Wu, X; Yuan, Q; Zhao, J | 1 |
Adalsteinsson, JA; Feng, H; Hu, C; Jonasson, JG; Kristjansson, AK; Muzumdar, S; Olafsdottir, GH; Ratner, D; Silverberg, JI; Tryggvadottir, L; Ungar, J; Waldman, R; Wu, R | 1 |
Biselli, JM; Biselli-Chicote, PM; Goloni-Bertollo, EM; Lotierzo, AT; Paravino, ÉC | 1 |
Islam, M; Kumar, B; Sharma, S; Teknos, TN | 1 |
4 other study(ies) available for atorvastatin and Carcinoma, Squamous Cell
Article | Year |
---|---|
Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma.
Topics: Atorvastatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Esophageal Neoplasms; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phosphorylation; Proteome; Xenograft Model Antitumor Assays | 2019 |
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
Topics: Atorvastatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iceland; Simvastatin; Skin Neoplasms | 2022 |
Atorvastatin increases oxidative stress and inhibits cell migration of oral squamous cell carcinoma in vitro.
Topics: Atorvastatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Mouth Neoplasms; Neovascularization, Physiologic; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Vascular Endothelial Growth Factor A | 2019 |
Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.
Topics: Animals; Atorvastatin; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Mice; Neoplasm Metastasis; Phosphorylation; Pyrroles; rho GTP-Binding Proteins; rhoC GTP-Binding Protein; STAT3 Transcription Factor | 2013 |